v3.26.3
Condensed Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 193,017 $ 601,010
Deferred offering costs 1,204,631 63,363
Prepaid expenses and other current assets 11,380 16,797
Total current assets 1,409,028 681,170
Total assets 1,409,028 681,170
Current liabilities    
Accounts payable 1,223,671 62,964
Accrued expenses 1,095,543 709,818
Warrant liability 1,415 11,323
Convertible promissory notes payable, related party 867,700 816,300
Total current liabilities 3,188,329 1,600,405
Total liabilities 3,188,329 1,600,405
Commitments and contingencies 0 0
Stockholders’ deficit    
Series A convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized; 5,661,422 shares issued and outstanding as of June 30, 2026 and December 31, 2025 566 566
Common shares, $0.0001 par value; 50,000,000 shares authorized; 5,263,158 shares issued and outstanding as of June 30, 2026 and December 31, 2025 526 526
Additional paid-in capital 9,921,159 9,921,343
Accumulated deficit (11,701,552) (10,841,670)
Total stockholders’ deficit (1,779,301) (919,235)
Total liabilities and stockholders’ deficit $ 1,409,028 $ 681,170